A study has determined that adverse effects leading to treatment discontinuation vary among different blood pressure-lowering drug classes.
The age-adjusted prevalence of hypertension among U.S. adults aged 18 years and older was recently found to be 29.1% in 2011-2012. 1 Prevalence increased with age, from 7.3% in persons aged 18 to 39 ...
The FDA has approved Widaplik, a triple-drug combination, for the treatment of hypertension in adults. Widaplik combines three drugs — telmisartan, amlodipine, and indapamide — into a single pill that ...
A 58-year-old woman is seen for routine care. She has a history of hypertension, obesity, hyperlipidemia, chronic kidney disease (CKD), prediabetes, and tobacco use disorder. She feels well today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results